Introduction
The human lung is a sensitive organ to ionizing radiation.1 Radiation-induced pulmonary injury (RIPI) could happen not only in radiotherapy for chest tumors, but also in practitioners receiving long-term low-dose radiation.2 Approximately 35% of lung and breast cancer patients would develop RIPI after chest radiation therapy.3 RIPI is mainly divided into three stages comprising the asymptomatic phase,4 radiation-induced pneumonitis,5 and radiation-induced lung fibrosis.6,7 When the disease progresses to the pulmonary fibrosis, this would cause not only irreversible damage to the respiratory system and affect the long-term quality of life, but also induce life-threatening respiratory failure.3,7 Hence, finding interventions to delay or reverse the development of RIPI remains a critical issue in current clinical practice. In particular, early therapeutic intervention could significantly improve survival in RIPI.
In addition, type II alveolar epithelial cells play an essential role in lung injury caused by ionizing radiation.3 Extensive type II alveolar epithelial cells would be damaged after radiation stimulated the release of pro-inflammatory cytokines, thus leading to aggravated lung inflammation, increased epithelial and endothelial cell injury, and enhanced proliferation of interstitial cells and interstitial edema.8
PIEZO1 is a mechanically sensitive ion channel discovered in recent years.9 It is expressed in various lung cells according to the epithelial cells (bronchus and alveolus) and endothelial cells.10–12 A recent study has found that cyclical hydrostatic pressure could trigger an inflammatory response by activating the ion channel PIEZO1 in myeloid cells of the lung.13 Similarly, in the progress of RIPI, the damaged mechanical characteristics of the cellular microenvironment could also be sensed by PIEZO1.14
In addition to the change in the activation status of PIEZO1, whether there is a change in the PIEZO1 expression during RIPI is still unclear.
However, there are many studies confirming the relationship between miRNAs and lung injury. In an acute lung injury model, miRNA-1246 could mediate lung inflammation and apoptosis through NF-κB activation and Wnt/β-catenin inhibition.15 One study found that miR-34b-3p, miR-96-5p, and miR-802-5p in C57BL/6 mice lung tissue were associated with TGF-β signaling after whole chest irradiation.16
Compared with normal bronchial epithelial cells, the miR-139-5p had a low expression in lung adenocarcinoma cells.17 Furthermore, the expression of miR-139-5p was significantly decreased after a single 3-Gy dose of irradiation for 4–8 h in breast cancer cells. Reduced miR-139-5p expression was related to radiotherapy resistance of breast cancer cells by upregulating the target genes.18 Several miRNAs predicting databases, such as TargetScanHuman 7.2,19 miRBase,20,21 and ENCORI,22 also predicted that PIEZO1 could be the target gene of miR-139-5p (Fig. 1a–c).23 Nevertheless, whether the impact of miR-139-5p on radiation-induced injury in type II alveolar epithelial cells depends on PIEZO1 signaling is still unknown.
Hypothesis
We hypothesize that during RIPI, PIEZO1 expression is enhanced following reduced expression of miR-139-5p, which would participate in the pathogenesis of RIPI in type II alveolar epithelial cells. Firstly, PIEZO1 would be predicted to be the target gene of miR-139-5p by some miRNAs target gene prediction resources.19 Previous research has proven that ionizing radiation could inhibit the expression of miR-139-5p and upregulate downstream target genes related to radiotherapy resistance.18 We thereby assume that ionizing radiation could upregulate the expression of PIEZO1 by downregulating miR-139-5p. Secondly, it was shown that PIEZO1 could promote HIF-1α accumulation in myeloid cells to regulate innate immunity and bleomycin-induced lung fibrosis.13 Thirdly, HIF-1α was involved in the pathogenesis of radiation-induced pneumonia.24 Thereby, this would seem reasonable to speculate that PIEZO1 could also be activated and aggravate lung inflammation through HIF-1α when type II alveolar epithelial cells were exposed to ionizing radiation (Fig. 2).
Statistical analysis
GraphPad software 8.0 (GraphPad Software, Inc., La Jolla, CA, USA) was used to perform the statistical analyses. Data were presented as the mean ± standard deviation (SD). Differences among groups were evaluated by a student’s t-test. Each experiment was repeated as three independent experiments unless specified. p < 0.05 was considered to be statistically significant.
Rationale for the hypothesis
RIPI and miR-139-5p
miR-139-5p was initially identified as a tumor suppressor gene in breast cancer,25 colorectal cancer,26 prostate cancer,27,28 and bladder cancer.29 It was also found to be an effective regulator of the radiotherapy response.30,31 After ionizing radiation, the expression of miR-139-5p was inhibited in breast cancer cells.18 This led to an increased expression of the miR-139-5p target genes related to radiotherapy resistance, such as POLQ, TOP1, TOP2A, and MAT2A.18 Conversely, miR-139-5p mimics have a strong synergistic effect with radiation in vitro and in vivo. Furthermore, miR-139-5p could modulate Notch1 signaling, and an overexpression of miR-139-5p could downregulate the expression of the Notch1 protein that could inhibit an epithelial-mesenchymal transition, which would be a critical process in the development of RIPI.32 Taken together, this evidence would suggest that miR-139-5p might play a role in RIPI.
PIEZO1 might be a downstream target gene of miR-139-5p
We chose the TargetScanHuman 7.2,19 miRBase,20,21 and ENCORI22 miRNA target predicting resources to search for potential miR-139-5p target genes related to RIPI. The above three databases all predicted that PIEZO1 was possibly a target of miR-139-5p, which the intersection of the three databases predictions had 238 genes (Fig. 1d). Two of the three databases displayed a high predictive score in PIEZO1, a target score of 82 in miRBase and 99 context++ score percentile in TargetScanHuman 7.2. More interestingly, the impacts of miR-139-5p and PIEZO1 expression on the survival of patients with breast cancer were contrasting.23 It was shown that a high expression of miR-139-5p (Fig. 1e) or low expression of PIEZO1 (Fig. 1f) was related to longer survival time in breast cancer patients. The inverse effects of miR-139-5p and PIEZO1 on the breast cancer prognosis were consistent with the prediction that miR-139-5p negatively regulated the PIEZO1 expression made by the miRNA target predicting databases.
PIEZO1 in type II alveolar epithelial cells
As a mechanically sensitive ion channel, PIEZO1 would be crucial for the generation of mechanically gated non-selective cation current and would play an important role in the process of mechanical transduction.33 Previous studies and data from the BioGPS database (http://biogps.org/ ) demonstrated that PIEZO1 was widely expressed in various kinds of lung (fetal lung and lung) cells, such as bronchial epithelial cells, lung endothelial cells,12,34 alveolar epithelial cells (types I and II), and so on.10,11 In the pulmonary endothelial cells, PIEZO1 was related to angiogenesis, hydrostatic pressure-induced pulmonary edema, and ventilator-induced lung injury.35,36 In the lung myeloid cells, PIEZO1 promoted HIF-1α stabilization to trigger inflammation under stress.13 In alveolar epithelial cells, mechanical stress during the respiratory cycle activated PIEZO1, consequently causing a Ca2+ influx, thereby releasing an alveolar surfactant.37 However, there has been no research to prove that the PIEZO1 protein in the alveolar epithelial cells could regulate RIPI.
PIEZO1 with RIPI
Radiation-induced lung injury includes acute radiation-induced pneumonia and chronic pulmonary fibrosis.5 In the process of pulmonary injury caused by ionizing radiation, the structure and composition of the extracellular matrix would be damaged, thus leading to high levels of stress and strain throughout the lung.14PIEZO1 could be activated due to changes in the mechanics of the cellular microenvironment.13 Our ongoing study using the rat type II alveolar epithelial cells (RLE-6TN) found that a single dose of 4-Gy radiation after 8 h increased both the mRNA and protein levels of PEIZO1 (Fig. 1g, h). The previous study demonstrated that PIEZO1 induced the EDN1 expression through the Ca2+ influx to drive the HIF-1α accumulation and inflammation in the lung myeloid cells.13 Simultaneously, HIF-1α signaling was found to play an essential role in RIPI.5 During RIPI, the type II alveolar epithelial cells could also act as a source of inflammation.3 Therefore, we further speculated that PIEZO1 could aggravate lung inflammation after radiation by regulating the HIF-1α signaling in type II alveolar epithelial cells.
Verification of the hypothesis and clinical implications
We proposed a novel mechanism whereby miR-139-5p would regulate PIEZO1/HIF-1α signaling to modulate ionizing radiation-induced pulmonary injury. PIEZO1 in type II alveolar epithelial cells could act as a potential target in protecting the lung from ionizing radiation injury. This hypothesis would be verified by a series of experiments. Firstly, we would confirm that the decreased expression of miR-139-5p would be accompanied with an increased PIEZO1 expression after ionizing radiation. Secondly, the miRNA/target gene relationship between miR-139-5p and PIEZO1 would be validated by a series of experiments. Thirdly, the roles of miR-139-5p and PIEZO1 in inflammation activated by the type II alveolar epithelial cells after radiation will be examined. Finally, an investigation would be undertaken to examine whether the impact of miR-139-5p on RIPI was dependent on PIEZO1/HIF-1α signaling.
Future directions
We further tend to conduct a study to confirm whether PIEZO1 could be modulated by miR-139-5p and would explore the specific mechanisms through molecular biology experiments.
Conclusions
Ionizing radiation inhibits miR-139-5p expression. PIEZO1 is a predicted downstream target of miR-139-5p. After radiation, the upregulation of the PIEZO1 expression could aggravate inflammation and promote the development of RIPI in type II alveolar epithelial cells. Therefore, well-designed experiments would be needed to verify this hypothesis.
Abbreviations
- RIPI:
Radiation-induced pulmonary injury
- RLE-6TN:
rat type II alveolar epithelial cells
Declarations
Acknowledgement
We thank the Department of Nuclear Radiation Injury and Monitoring for the technical assistance.
Funding
The authors did not receive any financial support for this publication.
Conflict of interest
All authors have no interests to declare.
Authors’ contributions
JH and YL collected the data and wrote the manuscript. XG and XL performed all the bioinformatic analyses. YL offered conceptual insight. YL and HZ suggested intellectual support and supervised the project, and SW helped interpret the work. HZ, XL, and SW participated in the design of the study.